Treatment of Fatty Liver Disease
The recommended treatment for fatty liver disease is lifestyle modification focused on weight loss of 7-10% through caloric restriction and regular physical activity, which has been shown to improve liver histology, reduce inflammation, and even improve fibrosis. 1
Dietary Interventions
- Follow a Mediterranean diet pattern, which has been shown to reduce liver fat even without weight loss 1, 2
- Implement caloric restriction of 500-1000 kcal/day to achieve weight loss of 500-1000g/week 3
- Aim for 7-10% weight loss to improve hepatic inflammation and fibrosis; even 5-7% weight loss can significantly reduce intrahepatic fat content 1, 4
- Avoid processed foods and beverages with added fructose, which have been associated with NAFLD development 1, 3
- Replace saturated fats with monounsaturated and polyunsaturated fats, especially omega-3 fatty acids 1
- Limit or avoid alcohol consumption, as it can exacerbate liver damage, especially in those with advanced disease 1, 3
Physical Activity Recommendations
- Engage in at least 150-300 minutes of moderate-intensity aerobic exercise per week (e.g., brisk walking, swimming) or 75-150 minutes of vigorous-intensity exercise 1
- Include resistance training as a complement to aerobic exercise, which can be particularly beneficial for those with poor cardiorespiratory fitness 1
- Any physical activity is better than none - even modest increases in activity can improve liver health 1
- Exercise alone, even without weight loss, can reduce hepatic fat content by improving insulin sensitivity 1, 4
Treatment Algorithm Based on Disease Severity
For All Patients with NAFLD:
- Implement lifestyle modifications (diet and exercise) 1
- Treat comorbidities (diabetes, hypertension, dyslipidemia) 1
For Patients Without NASH or Fibrosis:
- Focus solely on lifestyle modifications without pharmacotherapy 1, 3
- Monitor for disease progression with periodic non-invasive testing 3
For Patients with NASH or Fibrosis:
- Continue aggressive lifestyle modifications 1
- Consider pharmacological treatment in addition to lifestyle changes 1
- For non-diabetic patients with biopsy-proven NASH: Vitamin E may be considered, though caution is needed in those with prostate cancer 1, 3, 5
- For patients with or without diabetes and NASH: Pioglitazone may improve liver histology including fibrosis 1, 6
Monitoring and Follow-up
- Use non-invasive tests like NAFLD Fibrosis Score to identify patients at risk for advanced fibrosis 3
- Reserve liver biopsy for patients who would benefit most from diagnostic, therapeutic guidance, and prognostic perspectives 3
- Monitor for cardiovascular disease, which is the main driver of morbidity and mortality in NAFLD patients before the development of cirrhosis 3
Common Pitfalls and Caveats
- Rapid weight loss (>1kg/week) should be avoided as it may worsen liver disease 1
- Sustainability is key - choose dietary and exercise regimens that can be maintained long-term 1, 4
- No specific pharmacotherapy has been approved by regulatory agencies specifically for NAFLD treatment 1
- Weight regain can reverse the benefits of lifestyle intervention, emphasizing the importance of long-term maintenance strategies 4, 7
- Metformin is not recommended as a specific treatment for NAFLD as it has no significant effect on liver histology 3, 6